Leading life sciences executives Laura Ferro, Stephen Allen and Michael Lutz Join Board of Directors, bringing extensive industry and business experience.
A team of investigators has developed a cancer vaccine technology using live, attenuated pathogens as vectors. A feature of the vaccine causes these bacteria to self-destruct once they've done their job, making it safe for use in humans.